The global market for RSV mRNA Vaccine was valued at US$ 536 million in the year 2024 and is projected to reach a revised size of US$ 736 million by 2031, growing at a CAGR of 5.3% during the forecast period.

RSV mRNA Vaccine Market

RSV mRNA Vaccine is an mRNA vaccine targeting Respiratory Syncytial Virus (RSV). RSV is a common respiratory virus that can cause cold-like symptoms and lower respiratory tract infections, particularly in infants, toddlers, and older adults. The RSV mRNA Vaccine utilizes mRNA technology to introduce mRNA sequences encoding RSV virus antigens into human cells, thereby inducing an immune response against RSV. This vaccine offers advantages such as high efficiency, safety, and ease of production, providing a new solution for preventing RSV infections. By administering the RSV mRNA Vaccine, the risk of RSV infection can be effectively reduced, related symptoms can be alleviated, and complications caused by RSV infections can be decreased.

North American market for RSV mRNA Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for RSV mRNA Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of RSV mRNA Vaccine include Abogen Bio, Innorna, Starna Therapeutics, Hualan Biological Engineering, SINOVAC, Moderna, GSK, Pfizer, Sanofi, Nanoribo, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for RSV mRNA Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RSV mRNA Vaccine.

The RSV mRNA Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RSV mRNA Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the RSV mRNA Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of RSV mRNA Vaccine Market Report

Report Metric	Details
Report Name	RSV mRNA Vaccine Market
Accounted market size in year	US$ 536 million
Forecasted market size in 2031	US$ 736 million
CAGR	5.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Base Modification Technology m1Ψ Modification Technology
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abogen Bio, Innorna, Starna Therapeutics, Hualan Biological Engineering, SINOVAC, Moderna, GSK, Pfizer, Sanofi, Nanoribo, Immorna, AIM Vaccine, Shijiazhuang Pharma Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of RSV mRNA Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of RSV mRNA Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is RSV mRNA Vaccine Market growing?

Ans: The RSV mRNA Vaccine Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the RSV mRNA Vaccine Market size in 2031?

Ans: The RSV mRNA Vaccine Market size in 2031 will be US$ 736 million.

Who are the main players in the RSV mRNA Vaccine Market report?

Ans: The main players in the RSV mRNA Vaccine Market are Abogen Bio, Innorna, Starna Therapeutics, Hualan Biological Engineering, SINOVAC, Moderna, GSK, Pfizer, Sanofi, Nanoribo, Immorna, AIM Vaccine, Shijiazhuang Pharma Group

What are the Application segmentation covered in the RSV mRNA Vaccine Market report?

Ans: The Applications covered in the RSV mRNA Vaccine Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the RSV mRNA Vaccine Market report?

Ans: The Types covered in the RSV mRNA Vaccine Market report are Base Modification Technology, m1Ψ Modification Technology

1 RSV mRNA Vaccine Market Overview

1.1 Product Definition

1.2 RSV mRNA Vaccine by Type

1.2.1 Global RSV mRNA Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Base Modification Technology

1.2.3 m1Ψ Modification Technology

1.3 RSV mRNA Vaccine by Application

1.3.1 Global RSV mRNA Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global RSV mRNA Vaccine Market Size Estimates and Forecasts

1.4.1 Global RSV mRNA Vaccine Revenue 2020-2031

1.4.2 Global RSV mRNA Vaccine Sales 2020-2031

1.4.3 Global RSV mRNA Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 RSV mRNA Vaccine Market Competition by Manufacturers

2.1 Global RSV mRNA Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global RSV mRNA Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global RSV mRNA Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of RSV mRNA Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of RSV mRNA Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of RSV mRNA Vaccine, Product Type & Application

2.7 Global Key Manufacturers of RSV mRNA Vaccine, Date of Enter into This Industry

2.8 Global RSV mRNA Vaccine Market Competitive Situation and Trends

2.8.1 Global RSV mRNA Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest RSV mRNA Vaccine Players Market Share by Revenue

2.8.3 Global RSV mRNA Vaccine Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global RSV mRNA Vaccine Market Scenario by Region

3.1 Global RSV mRNA Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global RSV mRNA Vaccine Sales by Region: 2020-2031

3.2.1 Global RSV mRNA Vaccine Sales by Region: 2020-2025

3.2.2 Global RSV mRNA Vaccine Sales by Region: 2026-2031

3.3 Global RSV mRNA Vaccine Revenue by Region: 2020-2031

3.3.1 Global RSV mRNA Vaccine Revenue by Region: 2020-2025

3.3.2 Global RSV mRNA Vaccine Revenue by Region: 2026-2031

3.4 North America RSV mRNA Vaccine Market Facts & Figures by Country

3.4.1 North America RSV mRNA Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America RSV mRNA Vaccine Sales by Country (2020-2031)

3.4.3 North America RSV mRNA Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe RSV mRNA Vaccine Market Facts & Figures by Country

3.5.1 Europe RSV mRNA Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe RSV mRNA Vaccine Sales by Country (2020-2031)

3.5.3 Europe RSV mRNA Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific RSV mRNA Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific RSV mRNA Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific RSV mRNA Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific RSV mRNA Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America RSV mRNA Vaccine Market Facts & Figures by Country

3.7.1 Latin America RSV mRNA Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America RSV mRNA Vaccine Sales by Country (2020-2031)

3.7.3 Latin America RSV mRNA Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa RSV mRNA Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa RSV mRNA Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa RSV mRNA Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa RSV mRNA Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global RSV mRNA Vaccine Sales by Type (2020-2031)

4.1.1 Global RSV mRNA Vaccine Sales by Type (2020-2025)

4.1.2 Global RSV mRNA Vaccine Sales by Type (2026-2031)

4.1.3 Global RSV mRNA Vaccine Sales Market Share by Type (2020-2031)

4.2 Global RSV mRNA Vaccine Revenue by Type (2020-2031)

4.2.1 Global RSV mRNA Vaccine Revenue by Type (2020-2025)

4.2.2 Global RSV mRNA Vaccine Revenue by Type (2026-2031)

4.2.3 Global RSV mRNA Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global RSV mRNA Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global RSV mRNA Vaccine Sales by Application (2020-2031)

5.1.1 Global RSV mRNA Vaccine Sales by Application (2020-2025)

5.1.2 Global RSV mRNA Vaccine Sales by Application (2026-2031)

5.1.3 Global RSV mRNA Vaccine Sales Market Share by Application (2020-2031)

5.2 Global RSV mRNA Vaccine Revenue by Application (2020-2031)

5.2.1 Global RSV mRNA Vaccine Revenue by Application (2020-2025)

5.2.2 Global RSV mRNA Vaccine Revenue by Application (2026-2031)

5.2.3 Global RSV mRNA Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global RSV mRNA Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Abogen Bio

6.1.1 Abogen Bio Company Information

6.1.2 Abogen Bio Description and Business Overview

6.1.3 Abogen Bio RSV mRNA Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Abogen Bio RSV mRNA Vaccine Product Portfolio

6.1.5 Abogen Bio Recent Developments/Updates

6.2 Innorna

6.2.1 Innorna Company Information

6.2.2 Innorna Description and Business Overview

6.2.3 Innorna RSV mRNA Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Innorna RSV mRNA Vaccine Product Portfolio

6.2.5 Innorna Recent Developments/Updates

6.3 Starna Therapeutics

6.3.1 Starna Therapeutics Company Information

6.3.2 Starna Therapeutics Description and Business Overview

6.3.3 Starna Therapeutics RSV mRNA Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Starna Therapeutics RSV mRNA Vaccine Product Portfolio

6.3.5 Starna Therapeutics Recent Developments/Updates

6.4 Hualan Biological Engineering

6.4.1 Hualan Biological Engineering Company Information

6.4.2 Hualan Biological Engineering Description and Business Overview

6.4.3 Hualan Biological Engineering RSV mRNA Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Hualan Biological Engineering RSV mRNA Vaccine Product Portfolio

6.4.5 Hualan Biological Engineering Recent Developments/Updates

6.5 SINOVAC

6.5.1 SINOVAC Company Information

6.5.2 SINOVAC Description and Business Overview

6.5.3 SINOVAC RSV mRNA Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 SINOVAC RSV mRNA Vaccine Product Portfolio

6.5.5 SINOVAC Recent Developments/Updates

6.6 Moderna

6.6.1 Moderna Company Information

6.6.2 Moderna Description and Business Overview

6.6.3 Moderna RSV mRNA Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Moderna RSV mRNA Vaccine Product Portfolio

6.6.5 Moderna Recent Developments/Updates

6.7 GSK

6.7.1 GSK Company Information

6.7.2 GSK Description and Business Overview

6.7.3 GSK RSV mRNA Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 GSK RSV mRNA Vaccine Product Portfolio

6.7.5 GSK Recent Developments/Updates

6.8 Pfizer

6.8.1 Pfizer Company Information

6.8.2 Pfizer Description and Business Overview

6.8.3 Pfizer RSV mRNA Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Pfizer RSV mRNA Vaccine Product Portfolio

6.8.5 Pfizer Recent Developments/Updates

6.9 Sanofi

6.9.1 Sanofi Company Information

6.9.2 Sanofi Description and Business Overview

6.9.3 Sanofi RSV mRNA Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Sanofi RSV mRNA Vaccine Product Portfolio

6.9.5 Sanofi Recent Developments/Updates

6.10 Nanoribo

6.10.1 Nanoribo Company Information

6.10.2 Nanoribo Description and Business Overview

6.10.3 Nanoribo RSV mRNA Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Nanoribo RSV mRNA Vaccine Product Portfolio

6.10.5 Nanoribo Recent Developments/Updates

6.11 Immorna

6.11.1 Immorna Company Information

6.11.2 Immorna Description and Business Overview

6.11.3 Immorna RSV mRNA Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Immorna RSV mRNA Vaccine Product Portfolio

6.11.5 Immorna Recent Developments/Updates

6.12 AIM Vaccine

6.12.1 AIM Vaccine Company Information

6.12.2 AIM Vaccine Description and Business Overview

6.12.3 AIM Vaccine RSV mRNA Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.12.4 AIM Vaccine RSV mRNA Vaccine Product Portfolio

6.12.5 AIM Vaccine Recent Developments/Updates

6.13 Shijiazhuang Pharma Group

6.13.1 Shijiazhuang Pharma Group Company Information

6.13.2 Shijiazhuang Pharma Group Description and Business Overview

6.13.3 Shijiazhuang Pharma Group RSV mRNA Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Shijiazhuang Pharma Group RSV mRNA Vaccine Product Portfolio

6.13.5 Shijiazhuang Pharma Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 RSV mRNA Vaccine Industry Chain Analysis

7.2 RSV mRNA Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 RSV mRNA Vaccine Production Mode & Process Analysis

7.4 RSV mRNA Vaccine Sales and Marketing

7.4.1 RSV mRNA Vaccine Sales Channels

7.4.2 RSV mRNA Vaccine Distributors

7.5 RSV mRNA Vaccine Customer Analysis

8 RSV mRNA Vaccine Market Dynamics

8.1 RSV mRNA Vaccine Industry Trends

8.2 RSV mRNA Vaccine Market Drivers

8.3 RSV mRNA Vaccine Market Challenges

8.4 RSV mRNA Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Innorna

Starna Therapeutics

Hualan Biological Engineering

Shijiazhuang Pharma Group

Abogen Bio

Nanoribo

List of Tables

Table 1. Global RSV mRNA Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global RSV mRNA Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global RSV mRNA Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global RSV mRNA Vaccine Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global RSV mRNA Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global RSV mRNA Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global RSV mRNA Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market RSV mRNA Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of RSV mRNA Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of RSV mRNA Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of RSV mRNA Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of RSV mRNA Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global RSV mRNA Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RSV mRNA Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global RSV mRNA Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global RSV mRNA Vaccine Sales by Region (2020-2025) & (Units)

Table 18. Global RSV mRNA Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global RSV mRNA Vaccine Sales by Region (2026-2031) & (Units)

Table 20. Global RSV mRNA Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global RSV mRNA Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global RSV mRNA Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global RSV mRNA Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global RSV mRNA Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America RSV mRNA Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America RSV mRNA Vaccine Sales by Country (2020-2025) & (Units)

Table 27. North America RSV mRNA Vaccine Sales by Country (2026-2031) & (Units)

Table 28. North America RSV mRNA Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America RSV mRNA Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe RSV mRNA Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe RSV mRNA Vaccine Sales by Country (2020-2025) & (Units)

Table 32. Europe RSV mRNA Vaccine Sales by Country (2026-2031) & (Units)

Table 33. Europe RSV mRNA Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe RSV mRNA Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific RSV mRNA Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific RSV mRNA Vaccine Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific RSV mRNA Vaccine Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific RSV mRNA Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific RSV mRNA Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America RSV mRNA Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America RSV mRNA Vaccine Sales by Country (2020-2025) & (Units)

Table 42. Latin America RSV mRNA Vaccine Sales by Country (2026-2031) & (Units)

Table 43. Latin America RSV mRNA Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America RSV mRNA Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa RSV mRNA Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa RSV mRNA Vaccine Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa RSV mRNA Vaccine Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa RSV mRNA Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa RSV mRNA Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global RSV mRNA Vaccine Sales (Units) by Type (2020-2025)

Table 51. Global RSV mRNA Vaccine Sales (Units) by Type (2026-2031)

Table 52. Global RSV mRNA Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global RSV mRNA Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global RSV mRNA Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global RSV mRNA Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global RSV mRNA Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global RSV mRNA Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global RSV mRNA Vaccine Price (US$/Unit) by Type (2020-2025)

Table 59. Global RSV mRNA Vaccine Price (US$/Unit) by Type (2026-2031)

Table 60. Global RSV mRNA Vaccine Sales (Units) by Application (2020-2025)

Table 61. Global RSV mRNA Vaccine Sales (Units) by Application (2026-2031)

Table 62. Global RSV mRNA Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global RSV mRNA Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global RSV mRNA Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global RSV mRNA Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global RSV mRNA Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global RSV mRNA Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global RSV mRNA Vaccine Price (US$/Unit) by Application (2020-2025)

Table 69. Global RSV mRNA Vaccine Price (US$/Unit) by Application (2026-2031)

Table 70. Abogen Bio Company Information

Table 71. Abogen Bio Description and Business Overview

Table 72. Abogen Bio RSV mRNA Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Abogen Bio RSV mRNA Vaccine Product

Table 74. Abogen Bio Recent Developments/Updates

Table 75. Innorna Company Information

Table 76. Innorna Description and Business Overview

Table 77. Innorna RSV mRNA Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Innorna RSV mRNA Vaccine Product

Table 79. Innorna Recent Developments/Updates

Table 80. Starna Therapeutics Company Information

Table 81. Starna Therapeutics Description and Business Overview

Table 82. Starna Therapeutics RSV mRNA Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Starna Therapeutics RSV mRNA Vaccine Product

Table 84. Starna Therapeutics Recent Developments/Updates

Table 85. Hualan Biological Engineering Company Information

Table 86. Hualan Biological Engineering Description and Business Overview

Table 87. Hualan Biological Engineering RSV mRNA Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Hualan Biological Engineering RSV mRNA Vaccine Product

Table 89. Hualan Biological Engineering Recent Developments/Updates

Table 90. SINOVAC Company Information

Table 91. SINOVAC Description and Business Overview

Table 92. SINOVAC RSV mRNA Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. SINOVAC RSV mRNA Vaccine Product

Table 94. SINOVAC Recent Developments/Updates

Table 95. Moderna Company Information

Table 96. Moderna Description and Business Overview

Table 97. Moderna RSV mRNA Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Moderna RSV mRNA Vaccine Product

Table 99. Moderna Recent Developments/Updates

Table 100. GSK Company Information

Table 101. GSK Description and Business Overview

Table 102. GSK RSV mRNA Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. GSK RSV mRNA Vaccine Product

Table 104. GSK Recent Developments/Updates

Table 105. Pfizer Company Information

Table 106. Pfizer Description and Business Overview

Table 107. Pfizer RSV mRNA Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Pfizer RSV mRNA Vaccine Product

Table 109. Pfizer Recent Developments/Updates

Table 110. Sanofi Company Information

Table 111. Sanofi Description and Business Overview

Table 112. Sanofi RSV mRNA Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Sanofi RSV mRNA Vaccine Product

Table 114. Sanofi Recent Developments/Updates

Table 115. Nanoribo Company Information

Table 116. Nanoribo Description and Business Overview

Table 117. Nanoribo RSV mRNA Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Nanoribo RSV mRNA Vaccine Product

Table 119. Nanoribo Recent Developments/Updates

Table 120. Immorna Company Information

Table 121. Immorna Description and Business Overview

Table 122. Immorna RSV mRNA Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Immorna RSV mRNA Vaccine Product

Table 124. Immorna Recent Developments/Updates

Table 125. AIM Vaccine Company Information

Table 126. AIM Vaccine Description and Business Overview

Table 127. AIM Vaccine RSV mRNA Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. AIM Vaccine RSV mRNA Vaccine Product

Table 129. AIM Vaccine Recent Developments/Updates

Table 130. Shijiazhuang Pharma Group Company Information

Table 131. Shijiazhuang Pharma Group Description and Business Overview

Table 132. Shijiazhuang Pharma Group RSV mRNA Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Shijiazhuang Pharma Group RSV mRNA Vaccine Product

Table 134. Shijiazhuang Pharma Group Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. RSV mRNA Vaccine Distributors List

Table 138. RSV mRNA Vaccine Customers List

Table 139. RSV mRNA Vaccine Market Trends

Table 140. RSV mRNA Vaccine Market Drivers

Table 141. RSV mRNA Vaccine Market Challenges

Table 142. RSV mRNA Vaccine Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of RSV mRNA Vaccine

Figure 2. Global RSV mRNA Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global RSV mRNA Vaccine Market Share by Type: 2024 & 2031

Figure 4. Base Modification Technology Product Picture

Figure 5. m1Ψ Modification Technology Product Picture

Figure 6. Global RSV mRNA Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global RSV mRNA Vaccine Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Global RSV mRNA Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global RSV mRNA Vaccine Market Size (2020-2031) & (US$ Million)

Figure 13. Global RSV mRNA Vaccine Sales (2020-2031) & (Units)

Figure 14. Global RSV mRNA Vaccine Average Price (US$/Unit) & (2020-2031)

Figure 15. RSV mRNA Vaccine Report Years Considered

Figure 16. RSV mRNA Vaccine Sales Share by Manufacturers in 2024

Figure 17. Global RSV mRNA Vaccine Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest RSV mRNA Vaccine Players: Market Share by Revenue in RSV mRNA Vaccine in 2024

Figure 19. RSV mRNA Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global RSV mRNA Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America RSV mRNA Vaccine Sales Market Share by Country (2020-2031)

Figure 22. North America RSV mRNA Vaccine Revenue Market Share by Country (2020-2031)

Figure 23. United States RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe RSV mRNA Vaccine Sales Market Share by Country (2020-2031)

Figure 26. Europe RSV mRNA Vaccine Revenue Market Share by Country (2020-2031)

Figure 27. Germany RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific RSV mRNA Vaccine Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific RSV mRNA Vaccine Revenue Market Share by Region (2020-2031)

Figure 34. China RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America RSV mRNA Vaccine Sales Market Share by Country (2020-2031)

Figure 42. Latin America RSV mRNA Vaccine Revenue Market Share by Country (2020-2031)

Figure 43. Mexico RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa RSV mRNA Vaccine Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa RSV mRNA Vaccine Revenue Market Share by Country (2020-2031)

Figure 49. Turkey RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE RSV mRNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of RSV mRNA Vaccine by Type (2020-2031)

Figure 53. Global Revenue Market Share of RSV mRNA Vaccine by Type (2020-2031)

Figure 54. Global RSV mRNA Vaccine Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of RSV mRNA Vaccine by Application (2020-2031)

Figure 56. Global Revenue Market Share of RSV mRNA Vaccine by Application (2020-2031)

Figure 57. Global RSV mRNA Vaccine Price (US$/Unit) by Application (2020-2031)

Figure 58. RSV mRNA Vaccine Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human Respiratory Syncytial Virus RSV Treatment Market Research Report 2024

Global Respiratory Syncytial Virus Treatment Market Research Report 2024

Global Respiratory Syncytial Virus RSV Antigen and Antibody Reagent Market Research Report 2024

Global Respiratory Syncytial Virus Vaccine for the Elderly Market Research Report 2024

Global Respiratory Syncytial Virus Vaccine for Children Market Research Report 2024

Global Children Respiratory Syncytial Virus RSV Testing Market Research Report 2024

Respiratory Syncytial Virus Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Syncytial Virus Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Livestock mRNA Vaccines Market Research Report 2025

Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Virus Vaccines Market Research Report 2024

Global mRNA Vaccines Therapeutics Market Research Report 2024

Global mRNA Vaccines for Animals Market Research Report 2025

Respiratory Syncytial Virus Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Freeze Dried RSV mRNA Vaccine Market Research Report 2025

Respiratory Syncytial Virus RSV Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Syncytial Virus RSV Infections Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030

RSV Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions